SPECT imaging of striatal pre- and postsynaptic dopaminergic status in restless legs syndrome with periodic leg movements in sleep

被引:212
作者
Michaud, M
Soucy, JP
Chabli, A
Lavigne, G
Montplaisir, J
机构
[1] Univ Montreal, Fac Med, Dept Psychiat, Montreal, PQ H3C 3J7, Canada
[2] CHUM, Hop Notre Dame de Bon Secours, Dept Nucl Med, Montreal, PQ, Canada
[3] Univ Montreal, Fac Med Dent, Montreal, PQ H3C 3J7, Canada
关键词
restless legs syndrome (RLS); periodic leg movements during sleep (PLMS) single photon emission computed tomography (SPECT); dopamine; D-2-receptors;
D O I
10.1007/PL00007859
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Restless legs syndrome (RLS) is a common sleep-related disorder principally characterised by leg paresthesia associated with an irresistible urge to move. A majority of RLS patients experience periodic leg movements during sleep (PLMS) and wakefulness. Pharmacological evidence suggests that RLS-PLMS maybe caused by a central nervous system dopaminergic (DA) dysfunction. The aim of the present study was to evaluate the striatal pre- and postsynaptic DA status in patients suffering from both RLS and PLMS, by means of [I-123]beta-CIT and [I-123]IBZM SPECT respectively. Ten drug-naive patients and ten age-matched controls participated in this study. All participants were recorded for at least one night of polysomnography before the SPECT studies. No difference was seen in DA transporter ([I-123]beta-CIT) binding between RLS-PLMS patients (MD=4.89) and controls (MD=4.81; p=0.81). The study of the striatal D-2-receptor binding ([I-123]IBZM) revealed a significantly lower binding in patients (MD= 1.72) compared with controls (MD=1.85; p=0.006). These results support the hypothesis that a central DA dysfunction is involved in the physiopathology of RLS-PLMS. Several mechanisms may be responsible for the decrease of the D-2-receptor binding. However, since [I-123]beta-CIT binding is normal, a decreased number of D-2-receptors or a decreased affinity of D-2-receptors for [I-123]IBZM is more likely than an increased level of synaptic DA with attendant down-regulation of D-2-receptors.
引用
收藏
页码:164 / 170
页数:7
相关论文
共 63 条
[51]   Striatal dopaminergic function in restless legs syndrome -: 18F-dopa and 11C-raclopride PET studies [J].
Turjanski, N ;
Lee, AJ ;
Brooks, DJ .
NEUROLOGY, 1999, 52 (05) :932-937
[52]   EVALUATION OF [I-123] BETA-CIT BINDING WITH SPECT IN CONTROLS, EARLY AND LATE PARKINSONS-DISEASE [J].
VERMEULEN, RJ ;
WOLTERS, RC ;
TISSINGH, G ;
BOOIJ, J ;
JANSSEN, AGM ;
HABRAKEN, J ;
SOKOLEBUSEMANN, E ;
STOOF, JC ;
VANROYEN, EA .
NUCLEAR MEDICINE AND BIOLOGY, 1995, 22 (08) :985-991
[53]  
VONSCHEELE C, 1986, LANCET, V2, P426
[54]   LONG-TERM EFFECT OF DOPAMINERGIC DRUGS IN RESTLESS LEGS - A 2-YEAR FOLLOW-UP [J].
VONSCHEELE, C ;
KEMPI, V .
ARCHIVES OF NEUROLOGY, 1990, 47 (11) :1223-1224
[55]   A questionnaire study of 138 patients with restless legs syndrome: The 'Night-Walkers' survey [J].
Walters, AS ;
Hickey, K ;
Maltzman, J ;
Verrico, T ;
Joseph, D ;
Hening, W ;
Wilson, V ;
Chokroverty, S .
NEUROLOGY, 1996, 46 (01) :92-95
[56]   VARIABLE EXPRESSIVITY IN FAMILIAL RESTLESS LEGS SYNDROME [J].
WALTERS, AS ;
PICCHIETTI, D ;
HENING, W ;
LAZZARINI, A .
ARCHIVES OF NEUROLOGY, 1990, 47 (11) :1219-1220
[57]   A DOUBLE-BLIND RANDOMIZED CROSSOVER TRIAL OF BROMOCRIPTINE AND PLACEBO IN RESTLESS LEGS SYNDROME [J].
WALTERS, AS ;
HENING, WA ;
KAVEY, N ;
CHOKROVERTY, S ;
GIDROFRANK, S .
ANNALS OF NEUROLOGY, 1988, 24 (03) :455-458
[58]   TOWARD A BETTER DEFINITION OF THE RESTLESS LEGS SYNDROME [J].
WALTERS, AS .
MOVEMENT DISORDERS, 1995, 10 (05) :634-642
[59]   A randomized controlled study of pergolide in patients with restless legs syndrome [J].
Wetter, TC ;
Stiasny, K ;
Winkelmann, J ;
Buhlinger, A ;
Brandenburg, U ;
Penzel, T ;
Medori, R ;
Rubin, M ;
Oertel, WH ;
Trenkwalder, C .
NEUROLOGY, 1999, 52 (05) :944-950
[60]   Polysomnographic sleep measures in patients with uremic and idiopathic restless legs syndrome [J].
Wetter, TC ;
Stiasny, T ;
Kohnen, R ;
Oertel, WH ;
Trenkwalder, C .
MOVEMENT DISORDERS, 1998, 13 (05) :820-824